Skip to main content
OpenTrials

Clinical trial condition

Bipolar Disorder

Explore clinical trials studying Bipolar Disorder. Study availability and eligibility vary by location and protocol.

1,291 public trials 161 recruiting studies
Refine in advanced search Browse all conditions

Bipolar Disorder trial results

Recruiting

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

NCT06372964

Conditions
Bipolar Depression, Bipolar Disorder, Bipolar and Related Disorders, +2 more
Locations
  • Harmonex Neuroscience Research Dothan, Alabama, United States
  • Pillar Clinical Research, LLC Little Rock, Arkansas, United States
  • Advanced Research Center, Inc Anaheim, California, United States
  • Inland Psychiatric Medical Group Inc Redlands, California, United States
View all 68 locations
View Trial Details
Recruiting

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

NCT06229210

Conditions
Autism Spectrum Disorder, Bipolar Disorder, Bipolar and Related Disorders, +6 more
Locations
  • Southwest Autism Research and Resource Center Phoenix, Arizona, United States
  • Pillar Clinical Research, LLC Little Rock, Arkansas, United States
  • Advanced Research Center, Inc Anaheim, California, United States
  • National Institute Of Clinical Research Garden Grove, California, United States
View all 65 locations
View Trial Details
Recruiting

A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)

NCT07286175

Conditions
Bipolar Disorder, Bipolar and Related Disorders, Mental Disorders, +1 more
Locations
  • ATP Clinical Research Orange, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • AGA Clinical Trials Hialeah, Florida, United States
  • Accel Research Sites - Maitland Clinical Research Unit Maitland, Florida, United States
View all 87 locations
View Trial Details
Recruiting

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

NCT07105111

Conditions
Bipolar Disorder, Bipolar and Related Disorders, Central Nervous System Diseases, +17 more
Locations
  • Neurocrine Clinical Site Bryant, Arkansas, United States
  • Neurocrine Clinical Site Chino, California, United States
  • Neurocrine Clinical Site Fresno, California, United States
  • Neurocrine Clinical Site Long Beach, California, United States
View all 19 locations
View Trial Details

Related conditions